Literature DB >> 6632732

Lipoproteins, HDL-apolipoproteins, activities of hepatic lipase and lecithin-cholesterol acyltransferase in the plasma of patients with post-alcoholic end-stage liver cirrhosis.

C Breier, H J Lisch, H Braunsteiner.   

Abstract

12 patients with unequivocal post-alcoholic end-stage liver cirrhosis were compared with 12 healthy controls with regard to the plasma concentrations of lipids, lipoproteins (by rate zonal ultra-centrifugation) and apolipoproteins of high-density-lipoproteins (HDL) (by disc electrophoresis), as well as to the activities of lecithin-cholesterol acyltransferase (LCAT) in plasma and of hepatic lipase (HL) in post-heparin plasma. The cirrhotic group showed the following differences (all significant at the p less than 0.01 level) from the control group: Total cholesterol, HDL-cholesterol, very-low-density-lipoproteins (VLDL), HDL, and HL were decreased. Intermediate-density-lipoproteins (IDL) were not detectable in the cirrhotic group. Low-density-lipoproteins (LDL) did not differ significantly from controls. However, LDL from cirrhotic patients contained more triglycerides but less esterified and free cholesterol (all p less than 0.01). The percentage apolipoprotein composition of HDL did not differ significantly between controls and cirrhotics. Surprisingly, LCAT activity in plasma as well as the ratios between esterified and free cholesterol in plasma, LDL, and HDL were nearly identical in both groups. It seems likely that LCAT activity decreases only in the states of acute or subacute liver injury or of biliary obstruction. Severe chronic liver injury or of biliary obstruction. Severe chronic liver damage as in our cases of end-stage liver cirrhosis without any signs of acute liver injury exhibits apparently no defect in cholesterol esterification.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6632732     DOI: 10.1007/BF01537534

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  12 in total

1.  An enzymatic method for the determination of the initial rate of cholesterol esterification in human plasma.

Authors:  W Patsch; S Sailer; H Braunsteiner
Journal:  J Lipid Res       Date:  1976-03       Impact factor: 5.922

Review 2.  Lipoprotein structure and metabolism.

Authors:  R L Jackson; J D Morrisett; A M Gotto
Journal:  Physiol Rev       Date:  1976-04       Impact factor: 37.312

3.  Separation of the main lipoprotein density classes from human plasma by rate-zonal ultracentrifugation.

Authors:  J R Patsch; S Sailer; G Kostner; F Sandhofer; A Holasek; H Braunsteiner
Journal:  J Lipid Res       Date:  1974-07       Impact factor: 5.922

4.  Apolipoprotein CII and lipoprotein lipase in human nephrotic syndrome.

Authors:  M L Kashyap; L S Srivastava; B A Hynd; D Brady; G Perisutti; C J Glueck; P S Gartside
Journal:  Atherosclerosis       Date:  1980-01       Impact factor: 5.162

Review 5.  Plasma lipids and lipoproteins in liver disease.

Authors:  N McIntyre
Journal:  Gut       Date:  1978-06       Impact factor: 23.059

6.  High-density lipoprotein cholesterol and phospholipids, and apoprotein A in serum of patients with liver disease.

Authors:  J Rubiés-Prat; S Masdeu; A R Nubiola; P Chacón; C Holguera; L Masana
Journal:  Clin Chem       Date:  1982-03       Impact factor: 8.327

7.  [Changes in serum lipids and lipoproteins in acute hepatitis].

Authors:  R C Mordasini; S Berthold; E Schlumpf; G Riva
Journal:  Schweiz Med Wochenschr       Date:  1976-08-28

8.  Abnormal plasma lipoproteins and lecithin-cholesterol acyltransferase deficiency in alcoholic liver disease.

Authors:  S M Sabesin; H L Hawkins; L Kuiken; J B Ragland
Journal:  Gastroenterology       Date:  1977-03       Impact factor: 22.682

9.  [Concentrations of the main lipoprotein density classes in disturbances of thyroid function in man (author's transl)].

Authors:  H J Lisch; M Ogriseg; C Breier; H Drexel; H Fill; S Sailer
Journal:  Klin Wochenschr       Date:  1982-04-01

10.  Lipoprotein patterns in diet, sulphonylurea, and insulin treated diabetics.

Authors:  H J Lisch; S Sailer
Journal:  Diabetologia       Date:  1981-02       Impact factor: 10.122

View more
  4 in total

1.  [Reduction of post-heparin lipoprotein lipase activity by acidotic blood pH].

Authors:  C Breier; A Dzien; H J Lisch; H Braunsteiner
Journal:  Klin Wochenschr       Date:  1984-06-15

2.  Circulating sterols as predictors of early allograft dysfunction and clinical outcome in patients undergoing liver transplantation.

Authors:  Uta Ceglarek; Kathleen Kresse; Susen Becker; Georg Martin Fiedler; Joachim Thiery; Markus Quante; Robert Wieland; Michael Bartels; Gabriela Aust
Journal:  Metabolomics       Date:  2016-10-24       Impact factor: 4.290

3.  Proprotein convertase subtilisin/kexin type 9 (PCSK9) levels are not associated with severity of liver disease and are inversely related to cholesterol in a cohort of thirty eight patients with liver cirrhosis.

Authors:  Susanne Feder; Reiner Wiest; Thomas S Weiss; Charalampos Aslanidis; Doris Schacherer; Sabrina Krautbauer; Gerhard Liebisch; Christa Buechler
Journal:  Lipids Health Dis       Date:  2021-01-18       Impact factor: 3.876

4.  The Disturbance of Hepatic and Serous Lipids in Aristolochic Acid Ι Induced Rats for Hepatotoxicity Using Lipidomics Approach.

Authors:  Junyi Zhou; Yifei Yang; Hongjie Wang; Baolin Bian; Jian Yang; Xiaolu Wei; Yanyan Zhou; Nan Si; Haiyu Zhao
Journal:  Molecules       Date:  2019-10-17       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.